Decreased levels of glutathione, the major brain antioxidant, in post-mortem prefrontal cortex from patients with psychiatric disorders

International Journal of Neuropsychopharmacology

Volumn 14, Issue 1, 2011, Pages 123-130

  Gawryluk, Jeremy W ^a   Wang, Jun Feng ^a   Andreazza, Ana C ^a   Shao, Li ^a   Young, L Trevor ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Bipolar disorder; depression; glutathione; oxidative stress; schizophrenia.

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIOXIDANT; GLUTAMYL CYSTEINE LIGASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; MOOD STABILIZER; NEUROLEPTIC AGENT; OXIDOREDUCTASE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; AUTOPSY; BIPOLAR DISORDER; BRAIN HOMOGENATE; BRAIN LEVEL; BRAIN TISSUE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; MAJOR DEPRESSION; MALE; MENTAL PATIENT; OXIDATIVE STRESS; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SCHIZOPHRENIA; SPECTROPHOTOMETRY;

AGING; ANTIOXIDANTS; BIPOLAR DISORDER; DEPRESSIVE DISORDER, MAJOR; FEMALE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; HUMANS; HYDROGEN-ION CONCENTRATION; MALE; OXIDATION-REDUCTION; OXIDATIVE STRESS; PREFRONTAL CORTEX; REACTIVE OXYGEN SPECIES; SCHIZOPHRENIA; SUBSTANCE-RELATED DISORDERS;

EID: 79952775531     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145710000805     Document Type: Article

References (39)

1. Abdalla DS, Monteiro HP, Oliveira JA, Bechara EJ (1986). Activities of superoxide dismutase and glutathione peroxidase in schizophrenic and manic-depressive patients. Clinical Chemistry 32, 805-807. (Pubitemid 17028354)
2. Agarwal R, Shukla GS (1999). Potential role of cerebral glutathione in the maintenance of blood-brain barrier integrity in rat. Neurochemical Research 24, 1507-1514.
3. Altuntas I, Aksoy H, Coskun I, Caykoylu A, et al. (2000). Erythrocyte superoxide dismutase and glutathione peroxidase activities, and malondialdehyde and reduced glutathione levelsin schizophrenic patients. Clinical Chemistry and Laboratory Medicine 38, 1277-1281. (Pubitemid 32094401)
4. Andreazza AC, Cassini C, Rosa AR, Leite MC, et al. (2007). Serum 100B and antioxidant enzymes in bipolar patients. Journal of Psychiatric Research 41, 523-529. (Pubitemid 46227446)
5. Andreazza AC, Kauer-Sant'anna M, Frey BN, Bond DJ, et al. (2008). Oxidative stress markers in bipolar disorder: a meta-analysis. Journal of Affective Disorders 111, 135-144.
6. Andreazza AC, Shao L, Wang JF, Young LT (2010). Decreased mitochondrial complex I activity and increased oxidative damage to mitochondrial proteins in the prefrontal cortex of patients with bipolar disorder. Archives of General Psychiatry 67, 360-368.
7. Benes FM, Matzilevich D, Burke RE, Walsh J (2006). The expression of proapoptosis genes is increased in bipolar disorder, but not in schizophrenia. Molecular Psychiatry 11, 241-251.
8. Berk M, Copolov DL, Dean O, Lu K, Jeavons S, et al. (2008a). N-Acetyl cysteine for depressive symptoms in bipolar disorder - a double-blind randomized placebo-controlled trial. Biological Psychiatry 64, 468-475.
9. Berk M, Copolov DL, Dean O, Lu K, Jeavons S, et al. (2008b). N-Acetyl cysteine as a glutathione precursor for schizophrenia - a double blind, randomized, placebo-controlled trial. Biological Psychiatry 64, 361-368.
10. Bilici M, Efe H, Koroglu MA, Uydu HA, et al. (2001). Antioxidative enzyme activities and lipid peroxidation in major depression: alterations by antidepressant treatments. Journal of Affective Disorders 64, 43-51. (Pubitemid 32268670)
11. Che Y, Wang JF, Shao L, Young LT (in press). Oxidative damage to RNA but not DNA occurs in hippocampus of subjects with major mental illness. Journal of Psychiatry and Neuroscience.
12. Cui J, Shao L, Young LT, Wang JF (2007). Role of glutathione in neuroprotective effects of mood stabilizing drugs lithium and valproate. Neuroscience 144, 1447-1453. (Pubitemid 46123817)
13. Cumcurcu BE, Ozyurt H, Etikan I, Demir S, et al. (2009). Total antioxidant capacity and total oxidant status in patients with major depression: impact of antidepressant treatment. Psychiatry and Clinical Neurosciences 63, 639-645.
14. Dowlatshahi D, MacQueen G, Wang J, Reiach J, et al. (1999). G protein-coupled cyclic AMP signaling in postmortem brain of subjects with mood disorders: effects of diagnosis, suicide, and treatment at the time of death. Journal of Neurochemistry 73, 1121-1126. (Pubitemid 29395470)
15. Dringen R (2000). Metabolism and functions of glutathione in brain. Progress in Neurobiology 62, 649-671. (Pubitemid 30407139)
16. Eren I, Naziroglu M, Demirdas A (2007a). Protective effects of lamotrigine, apripiprazole and escitalopram on depression-induced oxidative stress in rat brain. Neurochemical Research 32, 1188-1195. (Pubitemid 46817468)
17. Eren I, Naziroglu M, Demirdas A, Celik O, et al. (2007b). Venlafaxine modulates depression-induced oxidative stress in brain and medulla of rat. Neurochemical Research 32, 497-505. (Pubitemid 46295149)
18. Grant JE, Odlaug BL, Kim SW (2009). N-Acetylcysteine, a glutamate modulator, in the treatment of trichotillomania. Archives of General Psychiatry 66, 756-763.
19. Halliwell B (2001). Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment. Drugs and Aging 18, 685-716. (Pubitemid 32948277)
20. Halliwell B, Gutteridge JR (2000). Free Radicals in Biology and Medicine, 3rd edn. Oxford: Clarendon.
21. Herken H, Uz E, Ozyurt H, Sogut S, et al. (2001). Evidence that the activities of erythrocyte free radical scavenging enzymes and the products of lipid peroxidation are increased in different forms of schizophrenia. Molecular Psychiatry 6, 66-73. (Pubitemid 32096067)
22. Knable MB, Barci BM, Webster MJ, Meador-Woodruff J, et al. (2004). Molecular abnormalities of the hippocampus in severe psychiatric illness: postmortem findings from the Stanley Neuropathology Consortium. Molecular Psychiatry 9, 609-620. (Pubitemid 38850441)
23. Kodydkova J, Vavrova L, Zeman M, Jirak R, et al. (2009). Antioxidant enzymes and increased oxidative stress in depressive women. Clinical Biochemistry 42, 1368-1374.
24. Lavoie S, Chen Y, Dalton TP, Gysin R, et al. (2009). Curcumin, quercetin, and tBHQ modulate glutathione levels in astrocytes and neurons: importance of the glutamate cysteine ligase modifier subunit. Journal of Neurochemistry 108, 1410-1422.
25. Lucca G, Comim CM, Valvassori SS, Gislaine ZR, et al. (2009a). Effects of chronic mild stress on the oxidative parameters in the rat brain. Neurochemistry International 54, 358-362.
26. Lucca G, Comim CM, Valvassori SS, Gislaine ZR, et al. (2009b). Increased oxidative stress in submitochondrial particles into the brain of rats submitted to the chronic mild stress paradigm. Journal of Psychiatric Research 43, 864-869.
27. Meister A (1983). Transport and metabolism of glutathione and gamma-glutamyl amino acids. Biochemical Society Transactions 11, 793-794. (Pubitemid 14177076)
28. Meister A (1988). Glutathione metabolism and its selective modification. Journal of Biological Chemistry 263, 17205-17208. (Pubitemid 19029311)
29. Ng F, Berk M, Dean O, Bush AI (2008). Oxidative stress in psychiatric disorders: evidence base and therapeutic implications. International Journal of Neuropsychopharmacology 11, 851-876.
30. Ozcan ME, Gulec M, Ozerol E, Polat R, et al. (2004). Antioxidant enzyme activities and oxidative stress in affective disorders. International Clinical Psychopharmacology 19, 89-95. (Pubitemid 38316767)
31. Prabakaran S, Swatton JE, Ryan MM, Huffaker SJ, et al. (2004). Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress. Molecular Psychiatry 9, 684-697. (Pubitemid 38932173)
32. Sarandol A, Sarandol E, Eker SS, Erdinc S, et al. (2007). Major depressive disorder is accompanied with oxidative stress: short-term antidepressant treatment does not alter oxidative-antioxidative systems. Human Psychopharmacology 22, 67-73. (Pubitemid 46505714)
33. Sun X, Wang JF, Tseng M, Young LT (2006). Down regulation in components of mitochondrial electron transport chain in post-mortem frontal cortex from subjects with bipolar disorder. Journal of Psychiatry Research 31, 189-196. (Pubitemid 43954738)
34. Tian SY, Wang JF, Bezchlibnyk YB, Young LT (2007). Immunoreactivity of 43 kDa growth-associated protein is decreased in post mortem hippocampus of bipolar disorder and schizophrenia. Neuroscience Letters 411, 123-127. (Pubitemid 44820684)
35. Torrey EF, Webster M, Knable M, Johnston N, et al. (2000). Stanley Foundation Brain Collection and Neuropathology Consortium. Schizophrenia Research 44, 151-155. (Pubitemid 30411930)
36. Tosic M, Ott J, Barral S, Bovet P, et al. (2006). Schizophrenia and oxidative stress: glutamate cysteine ligase modifier as a susceptibility gene. American Journal of Human Genetics 79, 586-592. (Pubitemid 44384270)
37. Wang JF, Shao L, Sun X, Young LT (2009). Increased oxidative stress in the anterior cingulate cortex of subjects with bipolar disorder and schizophrenia. Bipolar Disorders 11, 523-529.
38. Yanik M, Erel O, Kati M (2004). The relationship between potency of oxidative stress and severity of depression. Acta Neuropsychiatrica 16, 200-203. (Pubitemid 39663120)
39. Yao JK, Leonard S, Reddy R (2006). Altered glutathione redox state in schizophrenia. Disease Markers 22, 83-93. (Pubitemid 41831607)